Toru Mima

3.2k total citations · 1 hit paper
52 papers, 2.5k citations indexed

About

Toru Mima is a scholar working on Rheumatology, Nephrology and Oncology. According to data from OpenAlex, Toru Mima has authored 52 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Rheumatology, 17 papers in Nephrology and 12 papers in Oncology. Recurrent topics in Toru Mima's work include Parathyroid Disorders and Treatments (10 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Systemic Lupus Erythematosus Research (8 papers). Toru Mima is often cited by papers focused on Parathyroid Disorders and Treatments (10 papers), Rheumatoid Arthritis Research and Therapies (9 papers) and Systemic Lupus Erythematosus Research (8 papers). Toru Mima collaborates with scholars based in Japan, United States and United Kingdom. Toru Mima's co-authors include Norihiro Nishimoto, Hideko Nakahara, Yukihiko Saeki, Shiro Ohshima, Nobuhiro Takagi, Kimio Terao, Yoshinori Katada, Katsuhiro Nishioka, Masaki Suemura and Mitsuko Sasai and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Journal of Virology.

In The Last Decade

Toru Mima

52 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mechanisms and pathologic significances in increase in serum interleukin-6 (IL-6) and soluble IL-6 receptor after administration of an anti–IL-6 receptor antibody, tocilizumab, in patients with rheumatoid arthritis and Castleman disease

2008 587 citations Norihiro Nishimoto, Toru Mima et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Toru Mima Japan	23	941	764	676	579	377	52	2.5k
Yoshitaka Morita Japan	26	775 0.8×	1.0k 1.3×	659 1.0×	608 1.1×	296 0.8×	105	2.7k
Hoon‐Suk Cha South Korea	30	1.1k 1.2×	698 0.9×	725 1.1×	406 0.7×	344 0.9×	147	2.8k
Kunihiro Ichinose Japan	31	1.3k 1.4×	1.2k 1.6×	773 1.1×	316 0.5×	248 0.7×	188	3.1k
Shin‐ya Kawashiri Japan	27	1.3k 1.4×	745 1.0×	642 0.9×	374 0.6×	330 0.9×	223	3.0k
María Galindo-Izquierdo Spain	30	902 1.0×	853 1.1×	516 0.8×	478 0.8×	238 0.6×	114	2.6k
Mami Tamai Japan	30	1.7k 1.8×	1.0k 1.4×	689 1.0×	333 0.6×	414 1.1×	219	3.4k
Terry L. Moore United States	31	1.2k 1.3×	887 1.2×	646 1.0×	274 0.5×	882 2.3×	141	3.2k
Jason Jungsik Song South Korea	27	921 1.0×	468 0.6×	695 1.0×	307 0.5×	284 0.8×	215	2.7k
Gurtej S. Cheema United States	24	1.3k 1.4×	1.2k 1.6×	351 0.5×	266 0.5×	283 0.8×	26	2.9k
Seung Min Jung South Korea	27	963 1.0×	508 0.7×	549 0.8×	288 0.5×	248 0.7×	150	2.4k

Countries citing papers authored by Toru Mima

Since Specialization

Citations

This map shows the geographic impact of Toru Mima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toru Mima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toru Mima more than expected).

Fields of papers citing papers by Toru Mima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toru Mima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toru Mima. The network helps show where Toru Mima may publish in the future.

Co-authorship network of co-authors of Toru Mima

This figure shows the co-authorship network connecting the top 25 collaborators of Toru Mima. A scholar is included among the top collaborators of Toru Mima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toru Mima. Toru Mima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ohya, Masaki, Toru Mima, Kazuki Kawakami, et al.. (2020). Active vitamin D and vitamin D analogs stimulate fibroblast growth factor 23 production in osteocyte-like cells via the vitamin D receptor. Journal of Pharmaceutical and Biomedical Analysis. 182. 113139–113139. 12 indexed citations

Ohya, Masaki, et al.. (2018). Intravenous Maxacalcitol Therapy Correlates with Serum Fibroblast Growth Factor 23 Levels in Hemodialysis Patients Independent of Serum Phosphate or Calcium Levels. Contributions to nephrology. 196. 44–51. 1 indexed citations

Negi, Shigeo, et al.. (2018). Severe refractory infection due to renocolic fistula in a patient with a giant kidney and ADPKD undergoing long-term hemodialysis. CEN Case Reports. 7(1). 174–177. 3 indexed citations

Ohya, Masaki, Haruhisa Otani, Toru Mima, et al.. (2013). Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients. Clinical Nephrology. 80(7). 47–52. 20 indexed citations

Mima, Toru & Norihiro Nishimoto. (2009). Clinical value of blocking IL-6 receptor. Current Opinion in Rheumatology. 21(3). 224–230. 89 indexed citations

Mima, Toru, Hidehiko Sugino, Chieko Aoki, et al.. (2009). Interactions among type I and type II interferon, tumor necrosis factor, and β-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus. Arthritis Research & Therapy. 11(1). R1–R1. 45 indexed citations

Nishimoto, Norihiro, Hideko Nakahara, Naoko Yoshio‐Hoshino, & Toru Mima. (2008). Successful treatment of a patient with takayasu arteritis using a humanized anti–interleukin‐6 receptor antibody. Arthritis & Rheumatism. 58(4). 1197–1200. 130 indexed citations

Ohshima, Shiro, Masaru Ishii, Toru Mima, et al.. (2007). Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis. Clinical Rheumatology. 26(10). 1627–1633. 32 indexed citations

Katada, Yoshinori, Yoshinori Harada, Naoto Azuma, et al.. (2006). Minocycline-induced vasculitis fulfilling the criteria of polyarteritis nodosa. Modern Rheumatology. 16(4). 256–259. 14 indexed citations

10.

Ishii, Taeko, Hiroaki Onda, Akie Tanigawa, et al.. (2005). Isolation and Expression Profiling of Genes Upregulated in the Peripheral Blood Cells of Systemic Lupus Erythematosus Patients. DNA Research. 12(6). 429–439. 97 indexed citations

11.

Saiki, Osamu, N. Nishimoto, Takashi Miwa, et al.. (2004). Adult Still's disease reflects a Th2 rather than a Th1 cytokine profile. Clinical Immunology. 112(1). 120–125. 29 indexed citations

12.

Ishii, Taeko, Shiro Ohshima, Toru Mima, et al.. (2004). Osteopontin as a positive regulator in the osteoclastogenesis of arthritis. Biochemical and Biophysical Research Communications. 316(3). 809–815. 39 indexed citations

13.

Ishii, Taeko, Shiro Ohshima, Ichiro Kawase, et al.. (2004). Mice with osteopontin deletion remain predisposed to collagen‐induced arthritis. Arthritis & Rheumatism. 50(2). 669–671. 6 indexed citations

14.

Ohshima, Shiro, Hideyuki Kobayashi, Katsuhiro Nishioka, et al.. (2002). Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen‐induced arthritis: Possible involvement of osteopontin in bone destruction in arthritis. Arthritis & Rheumatism. 46(4). 1094–1101. 56 indexed citations

15.

Ohshima, Shiro, Toru Mima, Mitsuko Sasai, et al.. (2000). TUMOUR NECROSIS FACTOR α (TNF-α) INTERFERES WITH Fas-MEDIATED APOPTOTIC CELL DEATH ON RHEUMATOID ARTHRITIS (RA) SYNOVIAL CELLS: A POSSIBLE MECHANISM OF RHEUMATOID SYNOVIAL HYPERPLASIA AND A CLINICAL BENEFIT OF ANTI-TNF-α THERAPY FOR RA. Cytokine. 12(3). 281–288. 44 indexed citations

16.

Nishioka, Katsuhiro, Shiro Ohshima, Toru Mima, et al.. (2000). Enhanced expression and DNA binding activity of two CCAAT/enhancer-binding protein isoforms, C/EBPβ and C/EBPδ, in rheumatoid synovium. Arthritis & Rheumatism. 43(7). 1591–1596. 24 indexed citations

17.

Sasai, Mitsuko, Yukihiko Saeki, Shiro Ohshima, et al.. (1999). Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis & Rheumatism. 42(8). 1635–1643. 188 indexed citations

18.

Mima, Toru, Shiro Ohshima, Mitsuko Sasai, et al.. (1999). Dominant and Shared T Cell Receptor β Chain Variable Regions of T Cells Inducing Synovial Hyperplasia in Rheumatoid Arthritis. Biochemical and Biophysical Research Communications. 263(1). 172–180. 13 indexed citations

19.

Ohshima, Shiro, Yukihiko Saeki, Toru Mima, et al.. (1999). Long-Term Follow-Up of the Changes in Circulating Cytokines, Soluble Cytokine Receptors, and White Blood Cell Subset Counts in Patients with Rheumatoid Arthritis (RA) After Monoclonal Anti-TNFα Antibody Therapy. Journal of Clinical Immunology. 19(5). 305–313. 58 indexed citations

20.

Fujimura, Harutoshi, Yuji Nakatsuji, Saburo Sakoda, et al.. (1997). Demyelination in severe combined immunodeficient mice by intracisternal injection of cerebrospinal fluid cells from patients with multiple sclerosis: neuropathological investigation. Acta Neuropathologica. 93(6). 567–578. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact